Table 1 Baseline socio-demographic and clinical characteristics of 58 larynx-hypopharynx cancer patients, according to regular antiplatelets use
| Â | Non-Antiplatelets users | Antiplatelets users | Fisher exact test | ||
|---|---|---|---|---|---|
| Â | N | (%) | n | (%) | |
Sex | |||||
 Men | 34 | (89.5) | 16 | (80.0) | p = 0.43 |
 Women | 4 | (10.5) | 4 | (20.0) |  |
Age (years) | |||||
 <65 | 28 | (73.7) | 5 | (25.0) | p <0.01 |
 ≥65 | 10 | (26.3) | 15 | (75.0) |  |
Tobacco smoking | |||||
 Never | 5 | (13.2) | 4 | (20.0) | p = 0.70 |
 Ever | 33 | (86.8) | 16 | (80.0) |  |
T status | |||||
 T2–T3 | 27 | (71.0) | 20 | (100.0) | p = 0.01 |
 T4 | 11 | (29.0) | 0 | (0.0) |  |
N status | |||||
 N0 | 11 | (29.0) | 8 | (40.0) | p = 0.56 |
 N1–N3 | 27 | (71.0) | 12 | (60.0) |  |
Stage | |||||
 III | 13 | (34.2) | 15 | (75.0) | p <0.01 |
 IV | 25 | (65.8) | 5 | (25.0) |  |
Platelet count at radiotherapy beginning (cells/μL) | |||||
 <250.000 | 19 | (51.3) | 11 | (57.9) | p = 0.78 |
 ≥250.000 | 18 | (48.7) | 8 | (42.1) |  |
Locoregional recurrence | |||||
 No | 17 | (44.7) | 16 | (80.0) | p = 0.01 |
 Yes | 21 | (55.3) | 4 | (20.0) |  |